About this trial

The aim of the here proposed study is to assess safety, performance and provide real world evidence (RWE) of the Hamilton Medical AG automated mechanical ventilation software packages in consecutive critically ill patients admitted to the intensive care unit.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Non-invasive ventilation, Invasive mechanical ventilation, high-flow nasal oxygen

Treatment groups

1,000 Participants
are divided into 1 treatment group

Locations

4
HOCH Health Ostschweiz, Clinics for Intensive Care Medicine, Surgical ICU9007, Sankt GallenCanton of St. Gallen, Switzerland
Kantonsspital Chur7000, ChurKanton Graubünden, Switzerland
HOCH Health Ostschweiz, Clinics for Intensive Care Medicine, Medical ICU9007, Sankt GallenSt.Gallen, Switzerland
Kantonsspital Winterthur, Zentrum für Intensivmedizin8400, Winterthur Switzerland

Sponsors and collaborators

Hamilton Medical AG

Lead sponsor